A gold open access peer-reviewed journal publishing high-quality articles across all areas of rheumatology, osteoporosis and related disciplines. IF=4.2
Joined July 2020
- Tweets 216
- Following 165
- Followers 344
- Likes 138
22 Photos and videos
Thank you for such a thought-provoking and comprehensive congress #EULAR2024! See you next year in Barcelona
73
An interesting late-breaking abstract from our Editor-in-Chief
@DrPoddubnyy
on the last day of #EULAR2024 presenting a novel study design to test treat-to-target for patient's with #AxialSpondyloarthritis
2
89
Fantastic talk from Prof. Neil Basu at #EULAR2024 this morning on how partitioning musculoskeletal conditions into distinct pain mechanisms is not the most effective way to treat a patient's pain
1
2
99
Exciting new research on pre-diagnostic proteomic biomarkers for #Gout and predictive biomarkers for treatment response in #RheumatoidArthritis (and more!) presented at the first abstract session of #EULAR2024 yesterday!
Co-moderated by our Associate Editor @ChristianDejaco
34
A great first day at #EULAR2024. Especially @Lupusreference's engaging and accessible talk about what's on the horizon for #Lupus.
1
67
Using natural language processing to explore characteristics and management of patients with SpA (axSpA and PsA) in Spain. Check it out here: journals.sagepub.com/doi/10.β¦ @DiegoBenavent
1
5
207
Introducing our NEW Special Collection on Artificial Intelligence in Rheumatology!
π’ Open for submissions! Share your insights with us! ππ©βπ» #AI #Rheumatology @DiegoBenavent @vincevenerito @xabiermich
6
19
1,893
A new Special Collections is underway!
Psoriatic arthritis: Clinical, Diagnostic, and Therapeutic Aspects.
Guest Editors: @FragoulisGeorge @SteZhao
Find out more here: journals.sagepub.com/page/taβ¦
1
431
Therapeutic Advances in Musculoskeletal Disease retweeted
22 Sep 2023
Now published in @TAMuscDis: The effect of an IL-17A inhibitor on axial manifestations in patients with psoriatic arthritis from two Phase III clinical studies, SPIRIT-P1 and SPIRIT-P2. #PsA #psoriaticarthritis
Click here to access the full article: e.lilly/469DQko
1
2
13
139,976
How can we improve outcomes for PsA patients? Read more for the HIPPOCRATES programme. journals.sagepub.com/doi/10.β¦ @StefanSiebert1
2
3
1,336
Ixekizumab is effective in patients with Axial-PsA. Results from two phase III trials.
journals.sagepub.com/doi/ful⦠@DrPoddubnyy
1
2
327
New study shows Abatacept remains effective & safe in RA patients with previous malignancy, challenging previous inconsistent reports. π©Ίπ¬ #RheumatoidArthritis #MedicalResearch #abatacept
Check this out!
bit.ly/3OH8WJd
1
189
Therapeutic Advances in Musculoskeletal Disease retweeted
We are celebrating today as Therapeutic Advances in Rare Disease is now indexed in PubMed & Scopus!
A great milestone for the Journal!
Congratulations @Urvalind @maurizioscarpa @BCH_Rare @JemimaMellerio @votrubam @MariyaMoosajee @oligogirl @roon_mom @DrJohnBladen @SageJournals
1
5
146
π¬ Excited to be part of #EULAR2023! We've curated a special collection of articles just for this conference. Share knowledge, foster connections, spark dialogues. Let's change the future together! π·#Rheumatology #OpenAccess @SageClinMed
β‘οΈbit.ly/3ovhb1W
2
5
329
Therapeutic Advances in Musculoskeletal Disease retweeted
26 May 2023
10000 views reached !!! πππππ
Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge @TAMuscDis
Dima Alina, Jurcut Ciprian, Chasset Francois, Felten Renaud, Arnaud Laurent
journals.sagepub.com/doi/fulβ¦
3
13
1,137
Therapeutic Advances in Musculoskeletal Disease retweeted
New article online!
Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury
bit.ly/3WFgeRj
@SageClinMed @TAMuscDis
#OpenAccess #Osteoarthritis #KneeOsteoarthritis #TASeries #RheumTwitter
1
3
130
Any use of DMARDs in hand OA? Check out this updated review published in TAMD
journals.sagepub.com/doi/fulβ¦
1
86
π¬ Years of research, still no effective disease-modifying #osteoarthritis drugs (DMOADs) π. #MRI could be the key to success in future DMOAD trials.
@ali_guermazi @FrankRoemer1 Michel D. Crema, Mohamed Jarraya, Ali Mobasheri, Daichi Hayashi
Read more β‘οΈbit.ly/3N3Y8pl
160
π’ New review highlights the urgent need for more effective treatments for hand #osteoarthritis. π¦΄π
From Sara Tenti, @olibruyere, Sara Cheleschi, Jean-Yves Reginster, @ilmannato, Antonella Fioravanti
bit.ly/3L4jvFe
2
135